This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xopj1 [2020/06/30 17:42] rkoebnik [References] |
bacteria:t3e:xopj1 [2020/09/21 18:15] (current) rkoebnik [XopJ1] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== XopJ1 ====== | ====== XopJ1 ====== | ||
- | Author: Jens Boch\\ | + | Author: |
- | Internal reviewer: Joana Costa\\ | + | Internal reviewer: |
- | Expert reviewer: | + | Expert reviewer: |
Class: XopJ\\ | Class: XopJ\\ | ||
Family: XopJ1\\ | Family: XopJ1\\ | ||
- | Prototype: | + | Prototype: |
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 15: | Line 15: | ||
=== How discovered? === | === How discovered? === | ||
- | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // | + | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Line 24: | Line 24: | ||
=== Phenotypes === | === Phenotypes === | ||
- | Although a frameshift mutation of //xopJ// did not affect pathogenicity or bacterial growth in plants in early experiments (Noël //et al//., 2003), later studies showed that a //xopJ// mutant is slightly impaired in growth in pepper in late stages of the infection (Üstun //et al//., 2013). XopJ also suppresses | + | Although a frameshift mutation of //xopJ// did not affect pathogenicity or bacterial growth in plants in early experiments (Noël //et al//., 2003), later studies showed that a //xopJ// mutant is slightly impaired in growth in pepper in late stages of the infection (Üstun //et al//., 2013). XopJ also suppresses |
=== Localization === | === Localization === | ||
- | Following type III translocation, | + | XopJ carries a predicted N-myristoylation motif on a glycine residue at position two of the polypeptide. |
=== Enzymatic function === | === Enzymatic function === | ||
- | XopJ belongs to the group of YopJ-family effectors and is a member of the YopJ/AvrRxv family of SUMO peptidases and acetyltransferases. These are characterized as C55 cysteine proteases, ubiquitin-like proteases (deSUMOylation), | + | XopJ belongs to the group of YopJ-family effectors and is a member of the YopJ/AvrRxv family of SUMO peptidases and acetyltransferases. These are characterized as C55 cysteine proteases, ubiquitin-like proteases (deSUMOylation), |
=== Interaction partners === | === Interaction partners === | ||
- | 19S RP subunit RPT6 (RP ATPase 6) of the 26S proteasome (Üstun | + | 19S RP subunit RPT6 (RP ATPase 6) of the 26S proteasome (Üstün |
===== Conservation ===== | ===== Conservation ===== | ||
Line 45: | Line 44: | ||
Yes (//e.g.//, many // | Yes (//e.g.//, many // | ||
- | |||
===== References ===== | ===== References ===== | ||
Bartetzko V, Sonnewald S, Vogel F, Hartner K, Stadler R, Hammes UZ, Börnke F (2009). The // | Bartetzko V, Sonnewald S, Vogel F, Hartner K, Stadler R, Hammes UZ, Börnke F (2009). The // | ||
+ | |||
+ | Noël L, Thieme F, Gäbler J, Büttner D, Bonas U (2003). XopC and XopJ, two novel type III effector proteins from // | ||
Noël L, Thieme F, Nennstiel D, Bonas U (2001). cDNA-AFLP analysis unravels a genome-wide // | Noël L, Thieme F, Nennstiel D, Bonas U (2001). cDNA-AFLP analysis unravels a genome-wide // | ||
- | Noël L, Thieme F, Gäbler J, Büttner D, Bonas U (2003). XopC and XopJ, two novel type III effector proteins from // | + | Scheibner F, Hartmann N, Hausner J, Lorenz C, Hoffmeister |
- | + | ||
- | Scheibner F, Hartmann N, Hausner J, Lorenz C, Hoffmeister | + | |
Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | ||
Üstün S, Bartetzko V, Börnke F (2013). The // | Üstün S, Bartetzko V, Börnke F (2013). The // | ||
+ | |||
+ | Üstün S, Bartetzko V, Börnke F (2015). The // | ||
Üstün S, Börnke F (2014). Interactions of // | Üstün S, Börnke F (2014). Interactions of // | ||
Üstün S, Börnke F (2015). The // | Üstün S, Börnke F (2015). The // | ||
- | |||
- | Üstün S, Bartetzko V, Börnke F (2015). The // | ||
White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||